Trial intelligence / Profile preview

Melatonin for LV function in neonates with PPHN

NCT07090720Completed

Sponsor
Tanta University
Start
Jan 2023
Primary completion
Jan 2025
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial in persistent pulmonary hypertension of the newborn (PPHN) comparing Melatonin Group with Placebo Group (2 arms). Primary endpoint: Left ventricle global longitudinal strain at 1 hour. Started Jan 2023; status: completed.

02

Drugs

melatonin
03

Conditions

persistent pulmonary hypertension of the newborn (PPHN)

Beyond the preview

Go deeper on NCT07090720.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07090720.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call